Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water

Journal of Medicinal Food

Volumn 10, Issue 3, 2007, Pages 526-542

  Singh, Ashok K ^a   Jiang, Yin ^a   Benlhabib, Elhabib ^a   Gupta, Shveta ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Curcumin; Inflammation; Interleukins; Lipopolysaccharide; Nuclear factor B; Pleurisy; Polyenylphosphatidylcholine; Puerarin; Tumor necrosis factor ; Withdrawal symptoms

Indexed keywords

ACETALDEHYDE; ALCOHOL; CURCUMIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PHOSPHOLIPID DERIVATIVE; POLYENE PHOSPHATIDYLCHOLINE; PUERARIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALCOHOL WITHDRAWAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG ISOLATION; DRUG STABILITY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; HERB; KUDZU; MONOCYTE; MOUSE; NONHUMAN; PHYTOTHERAPY; PLANT ROOT; PLEURISY; PRIORITY JOURNAL; SOYBEAN;

ACETALDEHYDE; ALCOHOL-RELATED DISORDERS; ALCOHOLISM; ANIMALS; APOPTOSIS; CURCUMIN; ELECTROENCEPHALOGRAPHY; ETHANOL; FEMALE; HEPATITIS, ALCOHOLIC; INFLAMMATION; INTERLEUKIN-1BETA; ISOFLAVONES; LIVER; MATRIX METALLOPROTEINASE 9; MONOCYTES; PHOSPHATIDYLCHOLINES; PHYTOTHERAPY; PLEURAL EFFUSION; RATS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

CURCUMA LONGA; PUERARIA MONTANA VAR. LOBATA; RATTUS;

EID: 34848892155     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.228     Document Type: Article

References (78)

1. Mayo Clinic Report DS00340: Alcoholism, Mayo Clinic, Rochester, MN, 2004.
2. Balasekaran R, Bulterys M, Jamal MM, Quinn PG, Johnston DE, Skipper B, Chaturvedi S, Arora S: A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol 1999;94:1341-1346.
3. Frank J, Witte K, Schrodl W, Schutt C: Chronic alcoholism causes deleterious conditioning of innate immunity. Alcohol Alcohol 2004;39:386-392.
4. Gauthier TW, Drews-Botsch C, Falek A, Coles C, Brown LA: Maternal alcohol abuse and neonatal infection. Alcohol Clin Exp Res 2005;29:1035-1043.
5. Jerrells TR, Slukvin I, Sibley D, Fuseler J: Increased susceptibility of experimental animals to infectious organisms as a consequence of ethanol consumption. Alcohol Alcohol Suppl 1994;2:425-430.
6. Bruno A: Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Curr Neurol Neurosci Rep 2003;3:40-45.
7. Gullo L, Migliori M, Brunetti MA, Manca M: Alcoholic pancreatitis: new insights into an old disease. Curr Gastroenterol Rep 2005;7:96-100.
8. Jokelainen K, Reinke LA, Nanji AA: NFκB activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease. Cytokine 2001;16:36-39.
9. Kakizaki S, Hamada T, Yoshinaga T, Higuchi T, Kashiwabara K, Takagi H, Mori M: Alcoholic chronic pancreatitis with simultaneous multiple severe complications - extrahepatic portal obliteration, obstructive jaundice and duodenal stricture. Hepatogastroenterology 2005;52:1274-1277.
10. Rosenkranz S: Alcohol consumption and arterial hypertension. Dtsch Med Wochenschr 2003;128:2497-2502.
11. Said A, Williams J, Holden J, Remington P, Musat A, Lucey MR: The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting. Clin Gastroenterol Hepatol 2004;2:928-934.
12. Thurman RG, Bradford BU, Iimuro Y, Knecht KT, Connor HD, Adachi Y, Wall C, Arteel GE, Raleigh JA, Forman DT, Mason RP: Role of Kupffer cells, endotoxin and free radicals in hepatotoxicity due to prolonged alcohol consumption: studies in female and male rats. J Nutr 1997;127(Suppl):903S-906S.
13. Campbell IK, Gerondakis S, O'Donnell K, Wicks IP: Distinct roles for the NFκB and c-Rel transcription factors in inflammatory arthritis. J Clin Invest 2000;105:1799-1806.
14. Liberopoulos EN, Miltiadous GA, Elisaf MS: Alcohol intake, serum uric acid concentrations, and risk of gout. Lancet 2004;364:246-247.
15. Snaith M: Gout and alcohol. Rheumatology 2004;43:1208-1209.
16. Chandler LJ, Carpenter-Hyland E, Hendricson AW, Maldve RE, Morrisett RA, Zhou FC, Sari Y, Bell R, Szumlinski KK: Structural and functional modifications in glutamateric synapses following prolonged ethanol exposure. Alcohol Clin Exp Res 2006;30:368-676.
17. Cowen MS, Lawrence AJ: The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:1171-1212.
18. A receptors. Biochemistry (Mosc) 2002;67:719-729.
19. Heidbreder CA, Andreoli M, Marcon C, Thanos PK, Ashby CR Jr, Gardner EL: Role of dopamine D3 receptors in the addictive properties of ethanol. Drugs Today 2004;40:355-365.
20. Hoffman PL: NMDA receptors in alcoholism. Int Rev Neurobiol 2003;56:35-82.
21. Schumann G, Saam C, Heinz A, Mann K, Treutlein J: The NMDA receptor system: genetic risk factor for alcoholism. Nervenarzt 2005;76:1355-1362.
22. Crews FT. Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J: Cytokines and alcohol. Alcohol Clin Exp Res 2006;30:720-730.
23. Mittal N, Nathan JB, Pandey SC: Neuroadaptational changes in DNA binding of stimulatory protein-1 and nuclear factor-κB gene transcription factors during ethanol dependence. Eur J Pharmacol 1999;386:113-119.
24. Perrien DS, Liu Z, Wahl EC, Bunn RC, Skinner RA, Aronson J, Fowlkes J, Badger TM, Lumpkin CK Jr: Chronic ethanol exposure is associated with a local increase in TNF-alpha and decreased proliferation in the rat distraction gap. Cytokine 2003;23:179-189.
25. Singh AK, Jiang Y: Differential activation of NF kappa B/RelA-p50 and NF kappa B/p50-p50 in control and alcohol-drinking rats subjected to carrageenin-induced pleurisy. Mediat Inflam 2004;13:255-262.
26. Yao Z, Zhang J, Dai J, Keller ET: Ethanol activates NFkappaB DNA binding and p561ck protein tyrosine kinase in human osteoblast-like cells. Bone 2001;28:167-173. [Erratum in Bone 2001;29:403.]
27. Zakhari S: A prototypical cytokine-regulated transcription factor: implications for alcohol-mediated responses. Alcohol Clin Exp Res 1996;20(8 Suppl):236A-242A.
28. Collins GB, McAllister MS, Adury K: Drug adjuncts for treating alcohol dependence. Cleve Clin J Med 2006;73:641-644, 647-648, 650-651.
29. Miller NS, Gold MS: Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence. Am Fam Physician 1998;58:139-146.
30. Roozen HG, de Waart R, van der Windt DA, van den Brink W, de Jong CA, Kerkhof AJ: A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol 2006;16:311-323.
31. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP: The status of disulfiram: a half of a century later. J Clin Psychopharmacol 2006;26:290-302.
32. Carmen B, Angeles M, Ana M, Maria AJ: Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004;99:811-828.
33. Benlhabib E, Baker JI, Keyler DE, Singh AK: Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004;7:180-186.
34. Benlhabib E, Baker JI, Keyler DE, Singh AK: Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004;7:168-179.
35. Aleynik SI, Leo MA, Aleynik MK, Lieber CS: Alcohol-induced pancreatic oxidative stress: protection by phospholipid repletion. Free Radic Biol Med 1999;26:609-619.
36. Aleynik SI, Leo MA, Aleynik MK, Lieber CS: Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clin Exp Res 1998;22:192-196.
37. Aleynik SI, Lieber CS: Polyenylphosphatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring S-adenosyl-methionine. Alcohol Alcohol 2003;38:208-212.
38. Lieber CS, Robins SJ, Li J, DeCarli LM, Mak KM, Fasulo J M, Leo MA: Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994;106:152-159.
39. Lieber CS: Metabolism of alcohol. Clin Liver Dis 2005;9:1-35.
40. Blank ML, Robinson M, Fitzgerald V, Snyder S: Novel quantitative method for determination of molecular species of phospholipids and diglycerides. J Chromatogr 1984;298:473-482.
41. Jiang H, Timmermann BN, Gang DR: Use of liquid chromatography- electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric (Curcuma longa L.) rhizome. J Chromatogr A 2006;1111:21-31.
42. Jiang H, Somogyi A, Jacobsen NE, Timmermann BN, Gang DR: Analysis of curcuminoids by positive and negative electrospray ionization and tandem mass spectrometry. Rapid Commun Mass Spectrosc 2006;20:1001-1012.
43. Singh AK: Age-dependent neurotixicity in rats chronically exposed to low-levels of lead: calcium homeostasis in central neurons. Neurotoxicology 1993;14:417-427.
44. 32P]guanine triphosphate-azidoanilide of GTP-binding proteins in neurons isolated from brain of neonatal and adult rats. Biochem Pharmacol 1993;45:1107-1114.
45. Repnik U, Knezevic M, Jeras M: Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods 2003;278:283-292.
46. McCarver-May DG, Durisin L: An accurate, automated, simultaneous gas chromatographic headspace measurement of whole blood ethanol and acetaldehyde for human in vivo studies. J Anal Toxicol 1997;21:134-141.
47. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991;19:2499.
48. Godde WH, Agrawal DP: Alcoholism of Medical and Genetics Aspects, Pergamon Press, New York, 1989, pp. 3-57.
49. Higuchi S, Matsushita S, Murayama M, Takagi T, Hayashida M: Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 1995;152:1291-1221.
50. Agrawal DP: Genetic polymorphisms of alcohol metabolizing enzymes. Pathol Biol (Paris) 2001;49:703-709.
51. Martinez SE, Vaglenova SJ, Martinez MC, Farres J, Pares X: Distribution of alcohol dehydrogenase mRNA in the rat central nervous system. Eur J Biochem 2001;268:5045-5056.
52. Gaiter D, Carmine A, Buervenich S, Duester G, Olson L: Distribution of class I, II and IV alcohol dehydrogenase mRNAs in the adult rat mouse and human brain. Eur J Biochem 2003;270:1316-1326.
53. Deltour L, Foglio MH, Duester G: Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and metabolism of retinol to retinoic acid. J Biol Chem 1999;274:16796-16801.
54. Frezza M, DiPadova C, Pozzato G, Terpin M, Baraona E, Lieber CS: High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first pass metabolism. N Engl J Med 1990;322:95-99.
55. Norberg A, Jones AW, Hahn RG, Gabrielsson JL: Role of variability in explaining ethanol pharmacokinetics: research and forensic applications. Clin Pharmacokinet 2003;42:1-31.
56. Shin BS, Jun H, Lee D-E, Lee KR, Park ES, Yoo SD: Altered oral absorption by combined aqueous extracts of four herbal plants in rats. J Toxicol Environ Health A 2005;68:2219-2226.
57. Lin RC, Li T-K: Effects of isoflavones on alcohol pharmacokinetics and alcohol-drinking behavior in rats. Am J Clin Nutr 1989;68(Suppl):1512S- 1515S.
58. Cho M-H, Shim S-M, Lee S-R, Mar W, Kim G-H: Effects of Evodiae fructus on gene expression related with alcohol metabolism and antioxidation in ethanol-loaded mice. Food Chem Toxicol 2005;43:1365-1371.
59. Becker HC: Kindling in alcohol withdrawal. Alcohol Health Res World 1998;22:25-33.
60. Reuben A: Alcohol and the liver. Curr Opin Gastroenterol 2006;22:263-271.
61. Bergheim I, McClain CJ, Arteel GE: Treatment of alcoholic liver disease. Dig Dis 2005;23:275-284.
62. Stickel F, Seitz HK, Hahn EG, Schuppan D: Alcoholic liver disease-established treatment and new therapeutic approaches. Z Gastroenterol 2003;41:333-342.
63. Sougioultzis S, Dalakas E, Hayes PC, Plevris JN: Alcoholic hepatitis: from pathogenesis to treatment. Curr Med Res Opin 2005;21:1337-1346.
64. Yamashina S, Ikejima K, Enomoto N, Takei Y, Sato N: Glycine as a therapeutic immuno-nutrient for alcoholic liver disease. Alcohol Clin Exp Res 2005;29(11 Suppl):162S-165S.
65. Bouchier-Hayes L, Martin SJ: CARDINAL roles in apoptosis and NFkappaB activation. Vitamins Hormones 2004;67:133-147.
66. Celec P: Nuclear factor kappa B - molecular biomedicine: the next generation. Biomed Pharmacother 2004;58:365-371.
67. Liu SF, Malik AB: NF-κB activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 2006;290:L622-L645.
68. Sengchanthalangsy LL, Datta S, Huang DB, Anderson E, Braswell EH, Ghosh G: Characterization of the dimer interface of transcription factor NFkappaB p50 homodimer. J Mol Biol 1999;289:1029-1040.
69. Lee YB, Nagai A, Kim SU: Cytokines, chemokines and cytokine receptors in human microglia. J Neurosci Res 2002;69:94-103.
70. Guerra MC, Speroni E, Broccoli M, Cangini M, Pasini P, Minghett A, Crespi-Perellino N, Mirasoli M, Cantelli-Forti G, Paolini M: Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolite. Life Sci 2000;67:2997-3006.
71. Zhu ZT, Li HQ, Lu Y, Lou JS, Yao Z: Inhibitive effect of puerarin on increased NO production by neonatal cardiomyocytes during hypoxia/reoxygenation injury. J Chin Mater Med 2001;26:856-859.
72. Wu P, Zeng F, Ma HX: Study on effect of puerarin on nitric oxide system in rats' tissue and its mechanism. Chin J Integr Trad West Med 2001;21:196-198.
73. Muraoka K, Shimizu K, Sun X, Tani T, Izumi R, Miwa K, Yamamoto K: Flavonoids exert diverse inhibitory effects on the activation of NF-kappaB. Transplant Proc 2002;34:1335-1340.
74. Cao Q, Mak KM, Lieber CS: Dilinoleoylphosphatidylcholine decreases acetaldehyde-induced TNFα generation in Kupffer cells of ethanol-fed rats. Biochem Biophys Res Commun 2002;299:459-464.
75. Baraona E, Zeballos GA, Shoichet L, Mak KM, Lieber CS: Ethanol consumption increases nitric oxide production in rats, and its peroxynitrite-mediated toxicity is attenuated by polyenylphosphatidylcholine. Alcohol Clin Exp Res 2002;26:883-889.
76. Mak KI, Wen K, Ren C, Lieber CS: Dilinoleoylphosphatidylcholine reproduces that antiapoptotic actions of polyenylphos-phatidylcholine against ethanol-induced hepatocyte apoptosis. Alcohol Clin Exp Res 2003;27:997-1005.
77. Wessler S, Muenzner P, Meyer TF, Naumann M: The anti-inflammatory compound curcumin inhibits Neisseria gonorrhoeae-induced NFκB signaling, release of pro-inflammatory cytokines/chemokines and attenuates adhesion in late infection. Biol Chem 2005;386:481-490.
78. Masamune A, Suzuki N, Kikuta K, Satoh M, Satoh K: Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 2006;97:1080-1093.